Women’s Libido Drug Vyleesi Won FDA Approval, but Stock Investors Aren’t Happy - Barron's
Shares of the two companies behind Vyleesi, the newly approved women's libido drug, tumbled Monday. Both AMAG Pharmaceuticals and Palatin Technologies ...
View full coverage on Google News